• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定 DBC1 为 BRCA1 的转录抑制剂。

Identification of DBC1 as a transcriptional repressor for BRCA1.

机构信息

Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Hongo 7-3-1, Bunkyo-ku, Tokyo, Japan.

出版信息

Br J Cancer. 2010 Mar 16;102(6):1061-7. doi: 10.1038/sj.bjc.6605577. Epub 2010 Feb 16.

DOI:10.1038/sj.bjc.6605577
PMID:20160719
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2844029/
Abstract

BACKGROUND

DBC1/KIAA1967 (deleted in breast cancer 1) is a putative tumour-suppressor gene cloned from a heterozygously deleted region in breast cancer specimens. Caspase-dependent processing of DBC1 promotes apoptosis, and depletion of endogenous DBC1 negatively regulates p53-dependent apoptosis through its specific inhibition of SIRT1. Hereditary breast and ovarian cancer susceptibility gene product BRCA1, by binding to the promoter region of SIRT1, is a positive regulator of SIRT1 expression.

METHODS

A physical interaction between DBC1 and BRCA1 was investigated both in vivo and in vitro. To determine the pathophysiological significance of DBC1, its role as a transcriptional factor was studied.

RESULTS

We found a physical interaction between the amino terminus of DBC1 and the carboxyl terminus of BRCA1, also known as the BRCT domain. Endogenous DBC1 and BRCA1 form a complex in the nucleus of intact cells, which is exported to the cytoplasm during ultraviolet-induced apoptosis. We also showed that the expression of DBC1 represses the transcriptional activation function of BRCT by a transient expression assay. The expression of DBC1 also inhibits the transactivation of the SIRT1 promoter mediated by full-length BRCA1.

CONCLUSION

These results revealed that DBC1 may modulate the cellular functions of BRCA1 and have important implications in the understanding of carcinogenesis in breast tissue.

摘要

背景

DBC1/KIAA1967(乳腺癌 1 号缺失基因)是从乳腺癌标本的杂合缺失区域克隆出来的假定肿瘤抑制基因。DBC1 的半胱氨酸蛋白酶依赖性加工可促进细胞凋亡,而内源性 DBC1 的缺失通过其对 SIRT1 的特异性抑制,负调控 p53 依赖性细胞凋亡。遗传性乳腺癌和卵巢癌易感基因产物 BRCA1 通过与 SIRT1 启动子区域结合,正向调控 SIRT1 的表达。

方法

在体内和体外研究 DBC1 与 BRCA1 之间的物理相互作用。为了确定 DBC1 的病理生理意义,研究了其作为转录因子的作用。

结果

我们发现 DBC1 的氨基末端与 BRCA1 的羧基末端(也称为 BRCT 结构域)之间存在物理相互作用。内源性 DBC1 和 BRCA1 在完整细胞的核内形成复合物,在紫外线诱导的细胞凋亡过程中被输出到细胞质中。我们还表明,瞬时表达实验表明 DBC1 的表达抑制 BRCT 的转录激活功能。DBC1 的表达也抑制全长 BRCA1 介导的 SIRT1 启动子的转录激活。

结论

这些结果表明 DBC1 可能调节 BRCA1 的细胞功能,并对理解乳腺组织中的癌变具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df4d/2844029/31dcd0543098/6605577f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df4d/2844029/994f48d5cf68/6605577f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df4d/2844029/3be0e6f48606/6605577f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df4d/2844029/e0ef1f506091/6605577f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df4d/2844029/31dcd0543098/6605577f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df4d/2844029/994f48d5cf68/6605577f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df4d/2844029/3be0e6f48606/6605577f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df4d/2844029/e0ef1f506091/6605577f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df4d/2844029/31dcd0543098/6605577f4.jpg

相似文献

1
Identification of DBC1 as a transcriptional repressor for BRCA1.鉴定 DBC1 为 BRCA1 的转录抑制剂。
Br J Cancer. 2010 Mar 16;102(6):1061-7. doi: 10.1038/sj.bjc.6605577. Epub 2010 Feb 16.
2
Multifunctional transcription factor TFII-I is an activator of BRCA1 function.多功能转录因子 TFII-I 是 BRCA1 功能的激活剂。
Br J Cancer. 2011 Apr 12;104(8):1349-55. doi: 10.1038/bjc.2011.75. Epub 2011 Mar 15.
3
Repression of estrogen receptor beta function by putative tumor suppressor DBC1.通过潜在的肿瘤抑制因子 DBC1 抑制雌激素受体β的功能。
Biochem Biophys Res Commun. 2010 Feb 12;392(3):357-62. doi: 10.1016/j.bbrc.2010.01.025. Epub 2010 Jan 13.
4
MCC inhibits beta-catenin transcriptional activity by sequestering DBC1 in the cytoplasm.MCC 通过将 DBC1 隔离在细胞质中来抑制β-连环蛋白的转录活性。
Int J Cancer. 2015 Jan 1;136(1):55-64. doi: 10.1002/ijc.28967. Epub 2014 May 27.
5
Negative regulation of the deacetylase SIRT1 by DBC1.DBC1对去乙酰化酶SIRT1的负调控作用。
Nature. 2008 Jan 31;451(7178):587-90. doi: 10.1038/nature06515.
6
Role of deleted in breast cancer 1 (DBC1) protein in SIRT1 deacetylase activation induced by protein kinase A and AMP-activated protein kinase.蛋白激酶 A 和 AMP 激活的蛋白激酶诱导的 SIRT1 去乙酰化酶激活中缺失乳腺癌蛋白 1(DBC1)的作用。
J Biol Chem. 2012 Jul 6;287(28):23489-501. doi: 10.1074/jbc.M112.365874. Epub 2012 May 2.
7
HDAC3 is negatively regulated by the nuclear protein DBC1.组蛋白去乙酰化酶 3 受核蛋白 DBC1 的负调控。
J Biol Chem. 2010 Dec 24;285(52):40830-7. doi: 10.1074/jbc.M110.153270. Epub 2010 Oct 28.
8
DBC1 is a negative regulator of SIRT1.DBC1是SIRT1的负调控因子。
Nature. 2008 Jan 31;451(7178):583-6. doi: 10.1038/nature06500.
9
hMOF acetylation of DBC1/CCAR2 prevents binding and inhibition of SirT1.hMOF 对 DBC1/CCAR2 的乙酰化作用阻止了 SirT1 的结合和抑制。
Mol Cell Biol. 2013 Dec;33(24):4960-70. doi: 10.1128/MCB.00874-13. Epub 2013 Oct 14.
10
Balance between SIRT1 and DBC1 expression is lost in breast cancer.SIRT1 和 DBC1 的表达平衡在乳腺癌中丧失。
Cancer Sci. 2010 Jul;101(7):1738-44. doi: 10.1111/j.1349-7006.2010.01573.x. Epub 2010 Mar 24.

引用本文的文献

1
Adipocyte-specific deletion of Dbc1 does not recapitulate healthy obesity phenotype but suggests regulation of inflammation signaling.脂肪细胞特异性缺失Dbc1不会重现健康的肥胖表型,但提示炎症信号传导受到调控。
PLoS One. 2025 May 2;20(5):e0322732. doi: 10.1371/journal.pone.0322732. eCollection 2025.
2
Recurrent somatic mutations of FAT family cadherins induce an aggressive phenotype and poor prognosis in anaplastic large cell lymphoma.FAT 家族钙黏蛋白的反复体细胞突变导致间变大细胞淋巴瘤表现出侵袭性表型和不良预后。
Br J Cancer. 2024 Dec;131(11):1781-1795. doi: 10.1038/s41416-024-02881-7. Epub 2024 Oct 30.
3
Multifaceted roles of CCAR family proteins in the DNA damage response and cancer.

本文引用的文献

1
Repression of estrogen receptor beta function by putative tumor suppressor DBC1.通过潜在的肿瘤抑制因子 DBC1 抑制雌激素受体β的功能。
Biochem Biophys Res Commun. 2010 Feb 12;392(3):357-62. doi: 10.1016/j.bbrc.2010.01.025. Epub 2010 Jan 13.
2
Expression of DBC1 and SIRT1 is associated with poor prognosis of gastric carcinoma.DBC1和SIRT1的表达与胃癌的不良预后相关。
Clin Cancer Res. 2009 Jul 1;15(13):4453-9. doi: 10.1158/1078-0432.CCR-08-3329. Epub 2009 Jun 9.
3
Interplay among BRCA1, SIRT1, and Survivin during BRCA1-associated tumorigenesis.
CCAR 家族蛋白在 DNA 损伤反应和癌症中的多方面作用。
Exp Mol Med. 2024 Feb;56(1):59-65. doi: 10.1038/s12276-023-01139-1. Epub 2024 Jan 4.
4
SUMO1-regulated DBC1 promotes p53-dependent stress-induced apoptosis of lens epithelial cells.SUMO1 调节的 DBC1 促进了 p53 依赖性应激诱导的晶状体上皮细胞凋亡。
Aging (Albany NY). 2023 Sep 7;15(17):8812-8832. doi: 10.18632/aging.205001.
5
Mechanistic insights into the dual role of CCAR2/DBC1 in cancer.深入了解 CCAR2/DBC1 在癌症中的双重作用的机制见解。
Exp Mol Med. 2023 Aug;55(8):1691-1701. doi: 10.1038/s12276-023-01058-1. Epub 2023 Aug 1.
6
ML216 Prevents DNA Damage-Induced Senescence by Modulating DBC1-BLM Interaction.ML216 通过调节 DBC1-BLM 相互作用来防止 DNA 损伤诱导的衰老。
Cells. 2022 Dec 29;12(1):145. doi: 10.3390/cells12010145.
7
MED1, a novel binding partner of BRCA1, regulates homologous recombination and R-loop processing.MED1,BRCA1 的新型结合伴侣,调节同源重组和 R 环处理。
Sci Rep. 2022 Oct 13;12(1):17140. doi: 10.1038/s41598-022-21495-8.
8
Therapeutic implications of germline vulnerabilities in DNA repair for precision oncology.胚系 DNA 修复缺陷与精准肿瘤学的治疗相关性
Cancer Treat Rev. 2022 Mar;104:102337. doi: 10.1016/j.ctrv.2021.102337. Epub 2022 Jan 5.
9
DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer.癌症放疗增敏的 DNA 损伤反应信号通路和靶点。
Signal Transduct Target Ther. 2020 May 1;5(1):60. doi: 10.1038/s41392-020-0150-x.
10
The protein Deleted in Breast Cancer-1 (DBC1) regulates vascular response and formation of aortic dissection during Angiotensin II infusion.乳腺癌缺失基因 1(DBC1)蛋白调节血管反应和血管紧张素Ⅱ输注期间主动脉夹层的形成。
Sci Rep. 2020 Apr 21;10(1):6772. doi: 10.1038/s41598-020-63841-8.
BRCA1相关肿瘤发生过程中BRCA1、SIRT1和Survivin之间的相互作用。
Mol Cell. 2008 Oct 10;32(1):11-20. doi: 10.1016/j.molcel.2008.09.011.
4
Negative regulation of the deacetylase SIRT1 by DBC1.DBC1对去乙酰化酶SIRT1的负调控作用。
Nature. 2008 Jan 31;451(7178):587-90. doi: 10.1038/nature06515.
5
DBC1 is a negative regulator of SIRT1.DBC1是SIRT1的负调控因子。
Nature. 2008 Jan 31;451(7178):583-6. doi: 10.1038/nature06500.
6
SIRT1 promotes DNA repair activity and deacetylation of Ku70.沉默调节蛋白1促进DNA修复活性以及Ku70的去乙酰化作用。
Exp Mol Med. 2007 Feb 28;39(1):8-13. doi: 10.1038/emm.2007.2.
7
Role of estrogen receptor beta in uterine stroma and epithelium: Insights from estrogen receptor beta-/- mice.雌激素受体β在子宫基质和上皮中的作用:来自雌激素受体β基因敲除小鼠的见解
Proc Natl Acad Sci U S A. 2006 Nov 28;103(48):18350-5. doi: 10.1073/pnas.0608861103. Epub 2006 Nov 16.
8
An hGCN5/TRRAP histone acetyltransferase complex co-activates BRCA1 transactivation function through histone modification.一种人源GCN5/TRRAP组蛋白乙酰转移酶复合物通过组蛋白修饰共同激活BRCA1的反式激活功能。
J Biol Chem. 2006 Jan 6;281(1):20-6. doi: 10.1074/jbc.M510157200. Epub 2005 Oct 31.
9
Caspase-dependent processing activates the proapoptotic activity of deleted in breast cancer-1 during tumor necrosis factor-alpha-mediated death signaling.半胱天冬酶依赖性加工在肿瘤坏死因子-α介导的死亡信号传导过程中激活乳腺癌缺失基因1的促凋亡活性。
Oncogene. 2005 Jul 21;24(31):4908-20. doi: 10.1038/sj.onc.1208681.
10
Signalling DNA damage by regulating p53 co-factor activity.通过调节p53辅助因子活性来发出DNA损伤信号。
Cell Cycle. 2005 Jan;4(1):30-2. doi: 10.4161/cc.4.1.1397. Epub 2005 Jan 17.